Status:
UNKNOWN
Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly（Mrs AVS）
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
First Affiliated Hospital of Wenzhou Medical University
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Valvular Heart Disease
Eligibility:
All Genders
60-90 years
Brief Summary
Aortic valve stenosis (AVS) is becoming more and more frequent with the aging, which has brought a heavy burden to the world. However, the prevalence and prognosis of valvular heart disease are not so...
Eligibility Criteria
Inclusion
- 1\. Patients over 60 years old meet the following condition moderate or above aortic stenosis as defined by echocardiography: Aortic stenosis, moderate or above, or valve area≤1.5cm2, or maximal jet velocity ≥3.0m/sec, or mean pressure gradient≥20mmHg
Exclusion
- Patients cannot be followed up for any reasons.
- Patients in critical condition may be die in one year.
- Patients have been enrolled in this study.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03797820
Start Date
October 1 2018
End Date
September 30 2024
Last Update
July 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310000